PROF - Rasio utang marang kapitalisasi buku profoundmedical.com

Profound Medical Corp. (PROF) adheres to environmental standards by optimizing the packaging of its ultrasound therapy systems. This price chart reflects that the current figure is 0.15, while the business relies on physician trust through the creation of non-invasive methods for combating prostate tumors. The technological superiority of Profound Medical Corp. (PROF) in MRI-guided control is driven by massive R&D expenditures for the innovative TULSA-PRO system.

Investors use this ratio to assess financial stability and the extent of the issuer's dependence on external financing. The ratio of total liabilities to book capital, reflected in this chart of the debt-to-equity ratio, demonstrates the ability of Profound Medical Corp. (PROF) to develop high-tech robotic production of ultrasound therapy systems without a critical risk of default.